BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Clinical trials for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter radiation course tested for returning prostate cancer
Disease control Recruiting nowThis study compares two types of radiation therapy for men whose prostate cancer has returned or spread to a few spots after initial surgery. It tests if a shorter, more precise 5-treatment course (SBRT) works as well as a longer 20-treatment course, with potentially fewer side e…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Mayo clinic tests if less treatment works just as well for prostate cancer
Disease control Recruiting nowThis study is testing whether less aggressive treatment works as well as more intensive therapy for prostate cancer that has returned or spread. Researchers are comparing different approaches, including targeted radiation alone versus radiation combined with hormone-blocking drug…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Cancer care comes home: study tests if treatment outside clinic is better
Disease control Recruiting nowThis study is testing whether giving prostate cancer treatment at home is as safe and effective as receiving it in a clinic. Black men with advanced prostate cancer will receive part of their standard treatment at home with remote monitoring. Researchers want to see if home treat…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Major trial aims to outsmart prostate Cancer's return
Disease control Recruiting nowThis large study is testing if using a PET scan to guide treatment decisions helps control prostate cancer that returns after surgery. For about 800 men, the scan will determine if they receive standard radiation and hormone therapy alone, or if stronger drug therapy and targeted…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC